ArticleOPEN ACCESS

Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer (Oncotarget (2017) 8 (76974-76986) DOI: 10.18632/oncotarget.20293)

Oncotarget
ISSN: 19492553
4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

This article has been corrected: The correct author name and author contributed information is given below: Barbara Adamo1,*, Giuseppina Rosaria Rita Ricciardi2,*, Antonio Ieni3, Tindara Franchina2, Carmine Fazzari4, Maria Vita Sanò5, Giuseppe Angelico6, Michele Caruso5, Giovanni Tuccari3 and Vincenzo Adamo2

Cite

CITATION STYLE

APA

Adamo, B., Ricciardi, G. R. R., Ieni, A., Franchina, T., Fazzari, C., Sanò, M. V., … Adamo, V. (2019, January 1). Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer (Oncotarget (2017) 8 (76974-76986) DOI: 10.18632/oncotarget.20293). Oncotarget. Impact Journals LLC.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free